[1] |
Abalos E, Cuesta C, Carroli G, et al. WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health [J]. BJOG, 2014,121 Suppl 1: 14-24.
|
[2] |
Ronsmans C, Campbell O. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy [J]. BMC Public Health, 2011, 11 Suppl 3: S8.
|
[3] |
Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia [J]. Semin Perinatol, 2012, 36(1): 56-59.
|
[4] |
Huang Q, Liu L, Hu B, et al. Decreased seizure threshold in an eclampsia-like model induced in pregnant rats with lipopolysaccharide and pentylenetetrazol treatments [J]. PLoS One, 2014, 9(2): e89333.
|
[5] |
Liu L, Han X, Huang Q, et al. Increased neuronal seizure activity correlates with excessive systemic inflammation in a rat model of severe preeclampsia [J]. Hypertens Res, 2016, 39(10): 701-708.
|
[6] |
Li X, Han X, Yang J, et al. Magnesium Sulfate Provides Neuroprotection in Eclampsia-Like Seizure Model by Ameliorating Neuroinflammation and Brain Edema [J]. Mol Neurobiol, 2016 Nov 22.[Epub ahead of print]
|
[7] |
Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome [J]. N Engl J Med, 1996, 334(8): 494-500.
|
[8] |
Pula JH, Eggenberger E. Posterior reversible encephalopathy syndrome [J]. Curr Opin Ophthalmol, 2008, 19(6): 479-484.
|
[9] |
Casey SO, Sampaio RC, Michel E, et al. Posterior reversible encephalopathy syndrome utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions [J]. AJNR Am J Neuroradiol, 2000, 21(7): 1199-1206.
|
[10] |
Sengar AR, Gupta RK, Dhanuka AK, et al. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia [J]. AJNR Am J Neuroradiol, 1997, 18(8): 1485-1490.
|
[11] |
Matsuda H, Sakaguchi K, Shibasaki T, et al. Cerebral edema on MRI in severe preeclamptic women developing eclampsia [J]. J Perinat Med, 2005, 33(3): 199-205
|
[12] |
Zeeman GG, Fleckenstein JL, Twickler DM, et al. Cerebral infarction in eclampsia [J]. Am J Obstet Gynecol, 2004, 190(3): 714-720.
|
[13] |
Miguil M, Chekair A. Eclampsia, study of 342 cases [J]. Hypertension in Pregnancy, 2008, 27(2):103-111.
|
[14] |
Sheehan H, Lynch J. Pathology of toxemia of pregnancy [M]. Baltimore: Williams and Wilkins, 1973.
|
[15] |
Topuz S, Kalelioğlu I, Iyibozkurt AC, et al. Cranial imaging spectrum in hypertensive disease of pregnancy [J]. Clin Exp Obstet Gynecol, 2008, 35(3): 194-197.
|
[16] |
Berhan Y, Berhan A. Should magnesium sulfate is administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia [J]. Obstet Gynaecol Res, 2015, 41(6): 831-842.
|
[17] |
Hart LA, Sibai BM. Seizures in pregnancy: Epilepsy, eclampsia, and stroke [J]. Semin Perinatol, 2013, 37(4): 207-224.
|
[18] |
Karumanchi SA, Lindheimer MD. Advances in the understanding of eclampsia [J]. Curr Hypertens Rep, 2008, 10(4): 305-312.
|
[19] |
Foley MR, Strong TH, Garite TJ. Obstetric intensive care manual[M]. 4th ed. United State: McGraw-Hill education, 2014: 203-211.
|
[20] |
狄小丹,陈敦金,刘慧姝,等. 子痫并发溶血、肝酶升高、低血小板计数患者的发病特点及临床结局分析 [J]. 中华妇产科杂志,2010, 45(10): 740-744.
|
[21] |
Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial [J]. Lancet, 2002, 359(9321): 1877-1890.
|
[22] |
Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial [J]. Lancet, 1995, 345(8963): 1455-1463.
|
[23] |
Food and Drug Administration. FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies. FDA Drug Safety Communication. Silver Spring (MD): FDA; 2013. Available at: Retrieved June 12, 2013.
URL
|
[24] |
ACOG Practice Bulletin. Hypertension in pregnancy. American College of Obstetricians and Gynecologists [J]. Obstet Gynecol, 2013, 122(2 Pt 1):1122-1131.
|
[25] |
ACOG Practice committee opinion. Magnesium sulfate use in obstetrics. American College of Obstetricians and Gynecologists [J]. Obstet Gynecol, 2016, 127(1): e52-e53.
|
[26] |
ACOG Practice committee opinion. Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. American College of Obstetricians and Gynecologists [J]. Obstet Gynecol, 2017, 129(4): e90-e95.
|
[27] |
Lowe SA, Bowyer L, Lust K, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014 [J]. Aust N Z J Obstet Gynaecol, 2015, 55(5): e1-e29.
|
[28] |
Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial [J]. Am J Obstet Gynecol, 1997, 176(3): 623-627.
|
[29] |
Graham NM, Gimovsky AC, Roman A, et al. Blood loss at cesarean delivery in women on magnesium sulfate for preeclampsia [J]. J Matern Fetal Neonatal Med, 2016, 29(11): 1817-1821.
|
[30] |
Shah AK, Rajamani K, Whitty JE. Eclampsia: A neurological perspective [J]. J Neurol Sci, 2008, 271(1-2): 158-167.
|
[31] |
Aukes AM, de Groot JC, Aarnoudse JG, et al. Brain lesions several years after eclampsia [J]. Am J Obstet Gynecol, 2009, 200(5):504.e1-504.e5.
|
[32] |
Postma IR, Wessel I, Aarnoudse JG, et al. Neurocognitive functioning in formerly eclamptic women: Sustained attention and executive functioning [J]. Am J Perinatol, 2010, 27(9):685-690.
|